Evidence map›Paper›PMID 41543517›Full record

ArticleEnvironmental science & technology2026

SciRAPepi Tool: Optimization of the SciRAP Tool for Evaluating the Reliability and Relevance of Observational Epidemiological Studies for Hazard and Risk Assessment of Chemicals.

Henrieta Hlisníková, Anna Beronius

Abstract read
In one paragraph

Article in Environmental science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Henrieta HlisníkováInstitute of Environmental Medicine, Karolinska Institute, Nobels väg 13, 17177 Stockholm, Sweden.ORCID 0000-0003-0342-8830
Anna BeroniusInstitute of Environmental Medicine, Karolinska Institute, Nobels väg 13, 17177 Stockholm, Sweden.ORCID 0000-0001-9494-5395

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Science in Risk Assessment and Policy (SciRAP) platform has been developed to support the structured and transparent evaluation of data in hazard and risk assessment of chemicals. This work aimed to develop a SciRAP tool for the evaluation of the reliability and relevance of observational epidemiological studies (SciRAPepi tool), including cross-sectional, classical case-control, nested case-control, and cohort studies. A first version of the SciRAPepi tool was created, and an expert testing round was conducted to assess its scientific soundness and user-friendliness. Thirty-seven epidemiologists and risk assessors took part in the testing using the tool to evaluate four epidemiological studies representing the main epidemiological study designs. The majority of experts considered the criteria appropriate, and overall evaluations indicated good consistency across most criteria. Based on the testing results, the tool was further developed and refined. Together with the SciRAPepi tool, guidance and instructions on its use were developed, along with a reporting checklist to support researchers in reporting their studies. The SciRAPepi tool intends to enhance the use of reliable epidemiological data in the hazard and risk assessment of chemicals and other scientific assessments, offering a broader range of options for evaluating these data for epidemiologists and risk assessors.

Indexed as

Hazardous SubstancesEpidemiologic StudiesHumansReproducibility of ResultsRisk AssessmentHazardous Substancesevidence appraisal toolshazard and risk assessment of chemicalsobservational epidemiological studiesrelevancereliabilitySciRAPSciRAPepi tool

Identifiers

PMID41543517
PMCPMC12874513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.